Walleye Capital’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
Other funds holding ANAB
6CM
Walleye Capital's ANAB Position: Q3 2026 in Review
Walleye Capital opened a new position in AnaptysBio (ANAB) in Q3 2026: 8,695 shares worth $437K. The stake represents ﹤0.01% of the portfolio and ranks #4204 among its holdings. This is a return to the name: Walleye Capital previously reported a position in ANAB as recently as Q1 2026.
Walleye Capital first reported a position in ANAB in Q2 2019 and has held it in 12 quarters since. The position peaked at $5.49M in Q3 2024. 229 funds tracked by Wall St. Rank hold ANAB as of Q3 2026.
- Walleye Capital held 8,695 shares of AnaptysBio worth $437K as of Q3 2026.
- AnaptysBio was a new Walleye Capital position in Q3 2026.
- AnaptysBio made up ﹤0.01% of Walleye Capital's portfolio in Q3 2026, its #4204 holding.
- Walleye Capital first reported a position in AnaptysBio in Q2 2019 and has held it in 12 quarters since.
- Walleye Capital's AnaptysBio position peaked at $5.49M in Q3 2024.
- 229 funds tracked by Wall St. Rank held AnaptysBio as of Q3 2026.
Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.